Clinical Trial Update: Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dabrafenib and trametinib with or without hydroxychloroquine in stage IIIC or IV BRAF V600E/K melanoma; the study was terminated and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• MEKINIST (trametinib)
• Plaquenil (hydroxychloroquine)
• TAFINLAR (DABRAFENIB)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2024-08-22